Intricon Names Medical Device Veteran As New CFO
Intricon, today announced that it has named Shaun Blakeman as its CFO and newest member of its executive team.
Intricon, today announced that it has named Shaun Blakeman as its CFO and newest member of its executive team.
We are pleased to announce that Sara Hill, Chief Human Resources Officer has been recognized with the Twin Cities Business Monthly’s Most Notable in Recruitment and Talent award.
Material selection and effective navigation of regulatory requirements are two overlooked areas that directly impact wearable medical biosensor success. Learn more in this MD+DI article by Intricon’s Darren Gilmer and Craig Sandbulte.
NextFlex, America’s Flexible Hybrid Electronics Manufacturing Institute, recently interviewed Intricon’s Megan Brosnan about the company’s membership in NextFlex and its commitment to flexible-rigid hybrid (FHE) applications in medical-grade wearables.
Intricon’s CCTO Dave Liebl was recently featured in Medical Plastics News, discussing the main challenges for designing wearable medical devices. Learn about the 4 challenges that can be conquered at the design stage to enhance efficiency, cut costs, and expedite time to market.
Intricon announced its plans to open the first facility in Costa Rica dedicated to the production of sensor-driven medical devices.
Read more about best practices at the design stage to reduce delays and costs when bringing your biosensor device to the medical market.
A medical device company’s production equivalent failed design validation, threatening to derail the project via missed deadlines, inflated costs, and broken business promises. Suspecting a faulty electromagnetic sensor, the company turned to Intricon to salvage the project.
Electromagnetic components in interventional devices offer numerous advantages, but it takes careful optimization of EM sensors to maximize performance. Learn about the principles of EM navigation, sensor optimization, and key aspects of the design process from Intricon engineers.
A major medtech innovator’s supply chain was distressed when its supplier couldn’t resolve a product failure. This left existing patients with unusable devices and threatened the company’s ability to meet future demand. Seeking a rapid solution, the company turned to Intricon.